Article Sidebar

PDF (Tiếng Việt)
Published: 2024-05-31
Abstract Views: 26
Views PDF (Tiếng Việt): 29
DOI: https://doi.org/10.52852/tcncyh.v177i4E14.2274
Issue
Vol. 177 No. 4E14 (2024)
Section
Các bài báo
How to Cite
Thanh, D. D., Thuy, C. T. M., Tran, N. T. H., Hao, T. T. N., Khoa, V. N., Hien, N. V., & Bao, N. T. (2024). 7. Clinical, subclinical characteristics and treatment outcomes of patients with community - acquired pneumonia at risk of pes infection. Journal of Medical Research, 177(4E14), 48-56. https://doi.org/10.52852/tcncyh.v177i4E14.2274

7. Clinical, subclinical characteristics and treatment outcomes of patients with community - acquired pneumonia at risk of pes infection

Dang Duy Thanh, Cao Thi My Thuy, Nguyen Thi Hong Tran, Truong Thi Nhu Hao, Vo Nhat Khoa, Nguyen Vu Hien, Nguyen The Bao

Main Article Content

Abstract

This study aims to describe the clinical and subclinical characteristics and evaluate treatment outcomes of community-acquired pneumonia (CAP) patients at risk of Pseudomonas aeruginosa, extended-spectrum beta-lactamases-producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus (PES) infection. A cross-sectional descriptive study was conducted on 90 CAP patients with potential PES infection admitted to the Respiratory Department of Can Tho Central General Hospital in 2023. Most cases presented with symptoms, including moist rales (91.1%), increased cough (90%), dyspnea (86%), purulent sputum production (77.8%), and consolidation syndrome (71.1%). More than half of the cases exhibited fever (54.4%). A white blood cell count increase was typical (13.31 x 109 cells/L) and predominantly neutrophilic (81.3 ± 19.7%). Chest radiography predominantly showed bilateral infiltration (58.9%). PES pathogens were isolated in 30 patients (33.3%). The majority of cases did not respond to initial antibiotics (56.6%), most of the cases were stable and cured (accounting for 91.1%) with an average hospital stay of 8 days. Patients with CAP at risk of PES infection exhibit typical acute symptoms and laboratory features of conventional CAP. Most responded poorly to initial treatment, but the final treatment resulted in a very high rate of stability and cure.

Article Details

Keywords

Community-Acquired Pneumonia, Pseudomonas aeruginosa, Extended-spectrum beta-lactamases- producing Enterobacteriaceae, methicillin-resistant Staphylococcus aureus

References

1. Nicholson SC, Welte T, File TM Jr, et al. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation. Int J Antimicrob Agents. 2012; 39(3): 240-246. doi: 10.1016/j.ijantimicag.2011.11.005.
2. Prina E, Ranzani OT, Polverino E, et al. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thorac Soc. 2015; 12(2): 153-160. doi: 10.1513/AnnalsATS.201407-305OC.
3. Cillóniz C, Cardozo C, García-Vidal C. Epidemiology, pathophysiology, and microbiology of community-acquired pneumonia. Ann Res Hosp. 2018; 2:1. doi:10.21037/arh.2017.12.03.
4. Torres A, Chalmers JD, Dela Cruz CS, et al. Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med. 2019; 45(2): 159-171. doi: 10.1007/s00134-019-05519-y.
5. Ministry of Health. Instructions on internal medicine technical procedures in the respiratory field. Medical Publishing House, Hanoi. 2016.
6. Cillóniz C, Dominedò C, Nicolini A, Torres A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms. 2019; 7(2):49. doi: 10.3390/microorganisms7020049.
7. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2(Suppl 2): S27-72. doi: 10.1086/511159.
8. Duarte JC, Cordeiro CR, Ferreira AJ. Role of flexible bronchoscopy in non-resolving community-acquired pneumonia - A retrospective analysis. Rev Port Pneumol (2006). 2017; 23(3): 168-169. doi: 10.1016/j.rppnen.2017.01.009.
9. Ministry of Health. Decision No. 4815/QD-BYT. Decision on issuance of guidelines for diagnosis and treatment of community-acquired pneumonia in adults. 2020: 1-65.
10. Nguyen VT. Community-acquired pneumonia. Practicing internal medicine of pulmonary diseases. 2022: 38-58.
11. Ta TDN. Clinical, subclinical characteristics and etiology of community-acquired pneumonia. Medical thesis. Hanoi Medical University. 2016.
12. Nguyen TH. Research on clinical and bacteriological characteristics of community-acquired pneumonia caused by aerobic bacteria treated at the Respiratory Department, Bach Mai Hospital. Residential graduation thesis. Hanoi Medical University. 2003.
13. Le VT, Nguyen TN. Paraclinical characteristics of patients with community acquired pneumonia treatment in Xanh Pon General Hospital. Vietnamese Medical Journal. 2023; 527(1): 191-195. doi: 10.51298/vmj.v527i1.5662.
14. Cilloniz C, Dominedo C, Peroni HJ, et al. Difficult to treat microorganisms in patients aged over 80 years with community-acquired pneumonia: the prevalence of PES pathogens. Eur Respir J. 2020; 56(4):2000773. doi: 10.1183/13993003.00773-2020.
15. Tran HD, Bach Nguyen YT, Thanh Tran T, et al. Community-acquired pneumonia-causing bacteria and antibiotic resistance rate among Vietnamese patients: a cross-sectional study. Medicine (Baltimore). 2022; 101(36):e30458. doi: 10.1097/MD.0000000000030458.
16. Ministry of Health. Decision No. 708/QD-BYT. Decision on issuing guidelines for antibiotic use. 2015: 93-99.
17. Doan NTM, Vu VG, Nguyen HPA, Do VT. Investigation on management of community – acquired pneumonia on inpatients at Bach Mai Hospital from 10/2022 to 06/2023. Vietnamese Medical Journal. 2023; 530(1B): 107-112. doi: 10.51298/vmj.v530i1B.6686.